相关实验视频

Updated: May 24, 2025

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment

Published on: June 28, 2018

综合分子表征揭示了肺母细胞瘤的病变和治疗策略

He Tian^1,2, Zhenlin Yang¹, Junhui Yang³

¹Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.

Journal of the National Cancer Center

|March 5, 2025

概括

肺母细胞瘤 (PB) 是一种罕见的肺癌. 基因组分析揭示了DICER1的改变和途径失调是关键驱动因素,这表明选择患者的潜在免疫疗法.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
分子生物学分子生物学

背景情况:

肺母细胞瘤 (PB) 是一种罕见的肺癌,其致病性不明.
目前对PB的治疗选择有限,需要进一步研究其分子基础.

研究的目的:

阐明肺母细胞瘤的基因组和分子特征.
确定PB.潜在的致病机制和治疗点.

主要方法:

在七名PB患者身上进行了全外体测序 (WES),RNA测序和DNA甲基化分析.
从肺肉类瘤 (PSC) 和脑垂体母细胞瘤 (PitB) 的多omics数据被整合用于比较分析.

主要成果:

在PB中观察到的基因组变异率最高的是DICER1 (86%).
DICER1的改变,Wnt信号通路的失调以及IGF2的印记失调被确定为潜在的致病机制.
PB的分子特征与PSC不同,更像PitB. 较低的瘤突变负担 (TMB) 和白细胞分数 (LF) 被注意到,一些PD-L1阳性和CD8-阳性区域表明免疫治疗的潜力.

结论:

这项研究提供了肺母细胞瘤的综合分子概况.
介绍了对PB病变的新见解和潜在的治疗策略,包括针对特定病例的免疫疗法.

关键词:

多种经济体的个人资料.病变的发生和发病.肺内母细胞瘤是什么?治疗策略治疗策略

更多相关视频

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...